EVERSANA Builds on Commitment to “Pharmatize” AI with Amazon Web Services, Introduces Transformative Medical & Regulatory Review Solution

Nov 30, 2023 · Members in the News

The new generative-AI powered offering comes just months after the organizations came together to determine novel ways to leverage AI to solve complex challenges facing life sciences

Building on a promise to “pharmatize” artificial intelligence (AI) across the life sciences sector, EVERSANA®, a leading provider of commercial services to the global life sciences industry, today announced the first of several new generative AI-based innovations on Amazon Web Services (AWS) to drive greater efficiency and business value for companies and ultimately improved patient outcomes.

The first solution, developed by EVERSANA leveraging AWS and AWS Partner TensorIoT, addresses a time-consuming and error-prone process in the industry – medical and regulatory content approvals.  

Click here to read the full release